Raloxifene

DRAGON PHARMA RALOXIFENE

Raloxifene, manufactured by Dragon Pharma, is a powerful Selective Estrogen Receptor Modulator (SERM) designed to combat estrogenic side effects like gynecomastia in bodybuilders. Each tablet contains 60 mg of Raloxifene Hydrochloride and comes in a sachet with 100 tablets. This product is ideal for athletes and bodybuilders looking to protect themselves from unwanted estrogen-related issues during or after anabolic steroid use while maintaining the beneficial effects of estrogen in other tissues.

DRUG COMPOSITION

Active substance: Raloxifene Hydrochloride (60 mg per tablet)
Excipients: Stabilizers, binders, and fillers for product integrity and stability.

PHARMACEUTICAL FORM

Raloxifene is available in tablet form, allowing for easy and precise dosing, making it convenient to incorporate into a daily supplement regimen.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Selective Estrogen Receptor Modulator (SERM)
ATC Code: G03XC01 (Raloxifene)

PHARMACOLOGICAL PROPERTIES

Raloxifene acts as an estrogen receptor antagonist in breast tissue, blocking estrogen's ability to bind to receptors, which helps prevent gynecomastia. It selectively mimics the effects of estrogen in bones, helping to maintain bone density, and reduces the risk of estrogen-induced complications without causing water retention or fat gain. This makes Raloxifene a highly effective choice for athletes managing estrogen levels during and after steroid cycles.

PROFILE

• Chemical name: Raloxifene Hydrochloride
• Chemical formula: C28H28ClNO4S
• Percentage of anabolic activity: None
• Percentage of androgenic activity: None
• Active half life: 27-32 hours
• Recommended dosage: 60 mg per day
• Acne: None
• Bloating (water retention): None
• HBR: Unlikely
• Hepatic toxicity: Low
• Aromatization: None

THERAPEUTICAL INDICATIONS

Raloxifene is indicated for athletes and bodybuilders seeking to prevent or treat gynecomastia during anabolic steroid cycles. It is also used off-label for improving bone density and managing estrogenic effects post-cycle. Additionally, it can be used as part of a Post Cycle Therapy (PCT) plan to normalize hormone levels.

DOSES AND METHOD OF ADMINISTRATION

The recommended dosage for Raloxifene is 60 mg per day (one tablet). It is advised to take it with or without food, at a consistent time each day, to maintain stable blood levels. In bodybuilding, it can be started during or after a cycle where gynecomastia is a concern.

CYCLE/STACKING

Raloxifene can be stacked with other Dragon Pharma products for comprehensive protection against estrogenic side effects during steroid cycles:

• Cycle Example (8-12 weeks):

  • Raloxifene: 60 mg per day
  • Stack with Cypionat 250 (Testosterone Cypionate) 500 mg per week to enhance muscle mass and strength while minimizing estrogenic side effects.
  • Optionally add Anastrozole to further control estrogen levels.

• PCT Example (4-6 weeks):

  • Raloxifene: 60 mg per day
  • Combine with Clomid or Nolvadex to restore natural testosterone production and balance hormones after an anabolic steroid cycle.

POST CYCLE THERAPY

Raloxifene is highly effective in Post Cycle Therapy (PCT) for managing estrogen rebound and ensuring gynecomastia prevention. It helps reestablish hormonal balance and supports the body's natural testosterone production post-cycle.

SIDE EFFECTS

Common side effects may include hot flashes, leg cramps, or mild gastrointestinal discomfort. Serious side effects are rare but could include blood clots or stroke, particularly in individuals with pre-existing risk factors. If severe symptoms occur, discontinue use and seek medical advice.

CONTRAINDICATIONS

Raloxifene should not be used by individuals with a history of blood clots, stroke, or severe cardiovascular conditions. Pregnant or breastfeeding women should not take Raloxifene, as it may cause harm to the fetus or infant. Always consult with a healthcare professional before starting this product.

OVERDOSE

In the event of an overdose, seek immediate medical attention. Symptoms may include leg cramps, dizziness, or signs of blood clot formation. It is important to follow the recommended dosage closely.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Athletes using Raloxifene should be aware of its potential to increase the risk of blood clots. Regular medical check-ups are advised, especially if there are any cardiovascular concerns. Raloxifene is not a substitute for aromatase inhibitors (AI) but works effectively in combination to protect against gynecomastia.

INTERACTIONS WITH OTHER DRUGS

Raloxifene may interact with anticoagulants, cholesterol-lowering drugs, and certain hormonal therapies. Consult your healthcare provider if you are using any other medications before starting Raloxifene.

PRESENTATION, PACKAGING

Raloxifene by Dragon Pharma is presented in sachets containing 100 tablets, each providing 60 mg of Raloxifene Hydrochloride. The packaging is discreet and secure to ensure product safety during delivery.

STORAGE

Store in a cool, dry place away from direct sunlight. Keep out of reach of children. Recommended storage temperature: 15-25°C.

DELIVERY TO THE USA

We offer fast and discreet delivery of Dragon Pharma's Raloxifene to the USA. All orders are securely packaged to ensure privacy and safety during shipment.

LEGAL STATUS

Raloxifene is available by prescription in many countries, including the USA, where it is primarily prescribed for osteoporosis and breast cancer prevention. For bodybuilding purposes, it is considered an off-label use, so it is essential to verify your local regulations before purchase.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Ostarine National Library of Medicine, ncbi.nlm.nih.gov
• Raloxifene MedlinePlus, medlineplus.gov